Reconstructing and Reprogramming the Tumor-Propagating Potential of Glioblastoma Stem-like Cells-Reference-Cited by-同舟云学术

Reconstructing and Reprogramming the Tumor-Propagating Potential of Glioblastoma Stem-like Cells

Published:2014-04 Issue:3 Volume:157 Page:580-594
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Suvà Mario L.,Rheinbay Esther,Gillespie Shawn M.,Patel Anoop P.,Wakimoto Hiroaki,Rabkin Samuel D.,Riggi Nicolo,Chi Andrew S.,Cahill Daniel P.,Nahed Brian V.,Curry William T.,Martuza Robert L.,Rivera Miguel N.,Rossetti Nikki,Kasif Simon,Beik Samantha,Kadri Sabah,Tirosh Itay,Wortman Ivo,Shalek Alex K.,Rozenblatt-Rosen Orit,Regev Aviv,Louis David N.,Bernstein Bradley E.

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference63 articles.

1. TGF-β receptor inhibitors target the CD44(high)/Id1(high) glioma-initiating cell population in human glioblastoma;Anido;Cancer Cell,2010

2. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response;Bao;Nature,2006

3. Self-renewal does not predict tumor growth potential in mouse models of high-grade glioma;Barrett;Cancer Cell,2012

4. The EphA2 receptor drives self-renewal and tumorigenicity in stem-like tumor-propagating cells from human glioblastomas;Binda;Cancer Cell,2012

5. Functional and mechanistic diversity of distal transcription enhancers;Bulger;Cell,2011

Cited by 742 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell state plasticity in neuroblastoma;EJC Paediatric Oncology;2024-12

2. Prognostic significance of oligodendrocyte transcription factor 2 expression in glioma patients: A systematic review and meta-analysis;World Journal of Clinical Cases;2024-09-06

3. Brain development and bioenergetic changes;Neurobiology of Disease;2024-09

4. Differential requirement of m⁶A reader proteins, IGF2BP2 and HNRNPA2B1 for the processing of N⁶-methyladenosine modified H19 lncRNA: Stability versus miR-675 biogenesis;2024-08-08

5. Coordinated Targeting of S6K1/2 and AXL Disrupts Pyrimidine Biosynthesis in PTEN-Deficient Glioblastoma;Cancer Research Communications;2024-08-01